Eric R. Lutz - Concepedia

Author

Eric R. Lutz

Johns Hopkins University

Also Known As

E LUTZ, E. Lutz, Eric Lutz, Eric R Lutz, Eric R. Lutz

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Cancer Center Johns Hopkins Medicine Aduro BioTech (United States)

About

Eric R. Lutz is an author at Johns Hopkins University specializing in immunology, tumor immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Immunology	8	8	1.6K
3	Pathology	4	4	963
4	Cell Biology	3	3	590
5	Surgical Oncology	1	1	30

Eric R. Lutz

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Journal of Clinical Oncology	2015	588
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis Takahiro Tsujikawa, Sushil Kumar, Rohan N. Borkar, Cell Reports	2017	585
Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer Dung T. Le, Eric R. Lutz, Jennifer N. Uram, Journal of Immunotherapy ImmunologyGm-csf GeneImmune Cell TherapyImmunotherapyCancer Biology	2013	547
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Cancer Immunology Research ImmunologyImmune RegulationPathologyImmune Cell TherapyImmunotherapy	2014	521
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells Paul E. Zarek, Ching-Tai Huang, Eric R. Lutz, Blood	2007	490
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors Kevin C. Soares, Agnieszka A. Rucki, Annie A. Wu, Journal of Immunotherapy Pd-1/pd-l1 Blockade TogetherPd-l1 Antibody TherapyTumor ImmunologyLigand Pd-l1Pancreatic Cancer	2014	393
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction Dung T. Le, Dirk G. Brockstedt, Ran Nir‐Paz, Clinical Cancer Research	2011	361
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients Amy Thomas, Lynn M. Santarsiero, Eric R. Lutz, The Journal of Experimental Medicine	2004	347
Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation Dan Laheru, Eric R. Lutz, James M. Burke, Clinical Cancer Research	2008	343
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma Alexander C. Hopkins, Mark Yarchoan, Jennifer N. Durham, JCI Insight	2018	225

Page 1